BPTH logo

Bio-Path Holdings (BPTH) Company Overview

Profile

Full Name:

Bio-Path Holdings, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

March 4, 2008

Indexes:

Not included

Description:

Bio-Path Holdings (BPTH) is a biotechnology company focused on developing innovative cancer treatments. They specialize in RNA-based therapies that target cancer cells while minimizing damage to healthy tissue. Their goal is to improve patient outcomes through advanced, targeted therapies in oncology.

Events Calendar

Earnings

Next earnings date:

N/A

Recent quarterly earnings:

Nov 12, 2021

Recent annual earnings:

Mar 10, 2021
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Feb 23, 2024

Analyst ratings

Recent major analysts updates

Jul 8, 24 Roth MKM
Buy
Apr 18, 24 Roth MKM
Buy
Mar 27, 24 Roth MKM
Buy
May 19, 22 HC Wainwright & Co.
Buy
Mar 11, 21 Roth Capital
Buy
Nov 25, 20 Rodman & Renshaw
Buy
Nov 25, 20 HC Wainwright & Co.
Buy
Nov 25, 20 H.C. Wainwright
Buy
Nov 16, 20 HC Wainwright & Co.
Buy
Aug 17, 20 HC Wainwright & Co.
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Bio-Path Holdings?
  • Does Bio-Path Holdings pay dividends?
  • What sector is Bio-Path Holdings in?
  • What industry is Bio-Path Holdings in?
  • What country is Bio-Path Holdings based in?
  • When did Bio-Path Holdings go public?
  • Is Bio-Path Holdings in the S&P 500?
  • Is Bio-Path Holdings in the NASDAQ 100?
  • Is Bio-Path Holdings in the Dow Jones?
  • When was Bio-Path Holdings's last earnings report?
  • When does Bio-Path Holdings report earnings?
  • Should I buy Bio-Path Holdings stock now?

What is the ticker symbol for Bio-Path Holdings?

The ticker symbol for Bio-Path Holdings is NASDAQ:BPTH

Does Bio-Path Holdings pay dividends?

No, Bio-Path Holdings does not pay dividends

What sector is Bio-Path Holdings in?

Bio-Path Holdings is in the Healthcare sector

What industry is Bio-Path Holdings in?

Bio-Path Holdings is in the Biotechnology industry

What country is Bio-Path Holdings based in?

Bio-Path Holdings is headquartered in United States

When did Bio-Path Holdings go public?

Bio-Path Holdings's initial public offering (IPO) was on March 4, 2008

Is Bio-Path Holdings in the S&P 500?

No, Bio-Path Holdings is not included in the S&P 500 index

Is Bio-Path Holdings in the NASDAQ 100?

No, Bio-Path Holdings is not included in the NASDAQ 100 index

Is Bio-Path Holdings in the Dow Jones?

No, Bio-Path Holdings is not included in the Dow Jones index

When was Bio-Path Holdings's last earnings report?

Bio-Path Holdings's most recent earnings report was on Nov 12, 2021

When does Bio-Path Holdings report earnings?

The date for Bio-Path Holdings's next earnings report has not been announced yet

Should I buy Bio-Path Holdings stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions